Chemotherapy of systemic mycoses (second of two parts).
D000328:Adult; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D002648:Child; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007454:Iodides / Q000627:therapeutic use; D051379:Mice; D003904:Mitosporic Fungi / Q000187:drug effects; D013266:Stilbamidines / Q000627:therapeutic use; D014320:Triphenylmethyl Compounds / Q000627:therapeutic use
D000935:Antifungal Agents; D007093:Imidazoles; D007454:Iodides; D013266:Stilbamidines; D014320:Triphenylmethyl Compounds; D005437:Flucytosine